Based on these premises, we generated tumorspheres from the HCT116 CRC cell line and its SMYD3-KO counterpart to evaluate the effect of SMYD3 ablation or pharmacological inhibition on cancer cell proliferation and chemotherapy response in these more complex systems. This evidence concerns the gene SMYD3 and cancer.